(Q35166127)

6 August 2017

title

Effective immunomodulatory treatment of Escherichia coli experimental sepsis with thalidomide (English)

1 reference

Evangelos J Giamarellos-Bourboulis

6 August 2017

0 references

0 references

1 reference

1

object named as

Evangelos J Giamarellos-Bourboulis

1 reference

6 August 2017

7

Helen Giamarellou

1 reference

6 August 2017

Helen Poulaki

2

1 reference

6 August 2017

Nikolaos Kostomitsopoulos

3

1 reference

6 August 2017

Ismene Dontas

4

1 reference

6 August 2017

Despina Perrea

5

1 reference

6 August 2017

Panayotis E Karayannacos

6

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

Antimicrobial Agents and Chemotherapy

6 August 2017

published in

1 reference

6 August 2017

volume

47

1 reference

6 August 2017

issue

8

1 reference

6 August 2017

page(s)

2445-2449

1 reference

Thalidomide metabolism by the CYP2C subfamily.

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=166096

Use of IMiD3, a thalidomide analog, as an adjunct to therapy for experimental tuberculous meningitis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=166096

Immunological therapy of sepsis: experimental therapies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=166096

Thalidomide: current and potential clinical applications

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=166096

Immunomodulation by thalidomide and thalidomide analogues

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=166096

Single-dose pharmacokinetics of thalidomide in human immunodeficiency virus-infected patients

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=166096

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=166096

Laboratory models of sepsis and septic shock

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=166096

Thalidomide prevents alcoholic liver injury in rats through suppression of Kupffer cell sensitization and TNF-alpha production

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=166096

Safety, tolerability, and pharmacokinetic effects of thalidomide in patients infected with human immunodeficiency virus: AIDS Clinical Trials Group 267.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=166096

Pharmacokinetics and pharmacodynamics of thalidomide in HIV patients treated for oral aphthous ulcers: ACTG protocol 251. AIDS Clinical Trials Group

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=166096

Amelioration of experimental colitis by thalidomide.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=166096

A difference between the rat and mouse in the pharmacokinetic interaction of 5,6-dimethylxanthenone-4-acetic acid with thalidomide

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=166096

Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=166096

Protective effect of pentoxifylline plus thalidomide against septic shock in mice.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=166096

A combination of thalidomide plus antibiotics protects rabbits from mycobacterial meningitis-associated death

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=166096

Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients

27 September 2018

1 reference

12 December 2020

Rat intraperitoneal sepsis--a clinically relevant model

1 reference

12 December 2020

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis

1 reference

12 December 2020

Monocyte dysfunction in patients with Gaucher disease: evidence for interference of glucocerebroside with superoxide generation

1 reference

12 December 2020

Pharmacologic inhibitors of tumor necrosis factor production exert differential effects in lethal endotoxemia and in infection with live microorganisms in mice

1 reference

12 December 2020

Effects of dietary alpha- and gamma-linolenic acids on liver fatty acids, lipid metabolism, and survival in sepsis

1 reference

12 December 2020

Thalidomide inhibits tumor necrosis factor alpha, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats

1 reference

12 December 2020

Thalidomide inhibits TNF response and increases survival following endotoxin injection in rats

1 reference

12 December 2020

10.1128/AAC.47.8.2445-2449.2003

Identifiers

DOI

1 reference

6 August 2017

1 reference

6 August 2017

1 reference